This site is intended for health plan professionals in Canada.
U.S. professionals should visit ManagedCareCGM.com
Régie de l’assurance maladie du Québec Eases Requirements for Dexcom CGM Reimbursement – July 4, 2023
NIHB
Age 2+
Type 1 and Type 2
on any Insulin
*as of February 2024.
Continuous Glucose Monitoring (CGM) is a method to track glucose levels throughout the day and night. CGM systems take glucose measurements at regular intervals and translate the readings into dynamic data, providing glucose direction and rate of change. Having this context helps CGM users proactively manage glucose highs and lows, and gives added insight into impacts that meals, exercise and illness may have on an individual’s glucose levels. CGM can also contribute to better diabetes management by helping to minimize the guesswork that comes with making treatment decisions based solely on a number from a blood glucose meter reading. Studies have shown that CGM systems may help reduce A1C levels and reduce hypoglycemia, whether users are on insulin injections or pump therapy.
CGM Product Comparisons| Product Attributes and Performance |
G6® Continuous Glucose Monitoring System (Dexcom)1 |
FreeStyle® Libre Flash Glucose Monitoring System (Abbott)2 |
|---|---|---|
|
Monitoring Method |
Real-Time CGM |
Intermittent Scan CGM |
|
Data Availability |
Continuously available without user intervention |
Available with user intervention |
|
Age Indication |
2 years and older |
18 years and older |
|
Health Canada Approved Sensor Placement |
Upper Arm, Abdomen (adults) Abdomen, Upper Buttocks (pediatrics) |
Upper arm |
|
Factory Calibrated |
Yes (manual calibration optional) |
Yes |
|
Approved to Replace Fingerstick Blood Glucose Testing for Treatment Decisions |
Yes |
Yes Except fingerstick confirmation is required:
|
|
Approved to Aid in the Detection of Episodes of Hyperglycemia & Hypoglycemia |
Yes |
No |
|
Health Canada Warning for Patients Diagnosed with Hypoglycemia Unawareness |
No |
Yes |
|
Sensor Wear |
10 days |
14 days |
|
Sensor Survival [Adults ≥18] |
94% @ 10 days |
86% @ 14 days |
|
Sensor Expiration Warning |
Yes; 24 h, 6 h, 2 h, 30 min |
No |
|
Sensor Warm-up Time |
2 h |
1 h |
|
Water Resistance |
Up to 24 hours in 2.4 meters [8 feet] |
Up to 0.5 hours in 1 meter [3 feet] |
|
Known Interfering Substances |
Acetaminophen if dosed > 1 g every 6 h in adults |
Ascorbic Acid at >500 mg may cause falsely higher readings |
|
Approved for Use with Automated Insulin Delivery (AID) Systems |
Yes |
No |
|
Insulin Pump integration |
Yes Tandem t:slim X2® with AID |
No |
|
Mobile Device Connectivity |
Yes Apple iOS and Android via Bluetooth (See list of supported devices at http://www.dexcom.com/compatibility) |
Yes iOS and Android can be used to scan sensor for data via near field communication |
|
Smart Watch Compatibility |
Yes (See list of supported devices at http://www.dexcom.com/compatibility) |
No |
|
Protective Safeguards (Alerts/Alarms) |
||
|
Customizable Threshold Alerts / Alarms [Low / High] |
Yes |
No |
|
Predictive Low Glucose Alert [Within 20 mins] |
Yes |
No |
|
Urgent Low Glucose Alarm |
Yes |
No |
|
Rapidly Rising/Falling Rate of Change Alerts |
Yes (optional) |
No |
|
Alert Schedule [i.e. Different Alert Setting at Night] |
Yes (optional) |
No |
|
Share Alerts / Alarms |
Yes (optional) |
No |
|
Signal Loss Alert / Alarm |
Yes (optional) |
Yes |
|
Repeat Alerts / Alarms |
Yes (optional) |
No |
|
Accuracy |
||
|
MARD (Average % Discrepancy Between Sensor Readings and YSI Glucose) |
9.0% |
9.5% |
|
Percentage of Readings within ± 20% /± 1.11mmol/L |
94% |
91% |
|
Accuracy in Hypoglycemia: Concurrence of Sensor Readings with YSI-Measured Values in Low Range [Adult: 2.2-3.3 mmol/L] |
68% |
29% |
|
Data Management, Reporting & Sharing |
||
|
Data Availability |
Continuously available without user intervention |
Available with user intervention (i.e. user must scan sensor) |
|
Data Storage |
Automatically & continuously stored without user intervention |
Data stored when user scans sensor Sensor must be scanned at least once every 8 h to prevent data loss |
|
Data Sharing / Remote Monitoring |
Yes Readings continuously automatically shared with followers |
Yes Readings are shared when the user scans their sensor |
|
Trend Arrows |
Yes |
Yes |
|
Trend Graphs |
1, 3, 6, 12, 24 h |
8, 24 h |
|
Smart Phone Push Notifications with Insights, Coaching |
Yes Automated via Dexcom CLARITY® App Opt-In |
No |
|
Cloud-Based Data Management Program |
Yes Automated upload via Dexcom CLARITY® Mobile App |
Yes LibreView® Data stored and shared when user scans sensor Sensor must be scanned at least once every 8 h to prevent data loss |
Learn about the impact of diabetes on health outcomes, employee productivity, workplace safety and cost.
= Canadian Content
Gain insights into health plan policy developments and trends in the coverage of diabetes management technology.
= Canadian Content
Find the latest expert treatment guideline recommendations, clinical trials, and real-world evidence.
= Canadian Content
Review research on the cost effectiveness of CGM technology to guide value-based decision making.
= Canadian Content
Explore latest thinking and developments in digital health care for employees, including the role of CGM in virtual care and remote monitoring of diabetes.
= Canadian Content
Review findings on the clinical impact of hypoglycemia and its management with CGM.
= Canadian Content
Gain insights from leaders in the field of diabetes and health benefits in these Continuing Education activities.
= Canadian Content
Access non-CE education activities.
= Canadian Content
This website is supported by an educational grant from Dexcom, Inc.
